Kite, Humanigen to evaluate Yescarta, Lenzilumab combo in relapsed/refractory DLBCL

Image: Kite, Humanigen to evaluate Yescarta, Lenzilumab combo in relapsed/refractory DLBCL. Photo: courtesy of skeeze/Pixabay.